Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo

Genes and Development

Volumn 12, Issue 16, 1998, Pages 2469-2474

  Robles, Ana I ^a,b   Rodriguez Puebla, Marcelo L ^a   Glick, Adam B ^b   Trempus, Carol ^c   Hansen, Laura ^b   Sicinski, Piotr ^d   Tennant, Raymond W ^c   Weinberg, Robert A ^e   Yuspa, Stuart H ^b   Conti, Claudio J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Cell cycle; Keratinocyte; Knockout; Tg.AC; Two stage carcinogenesis

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; RAS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; KERATINOCYTE; MOUSE; NEWBORN; NONHUMAN; ONCOGENE H RAS; ONCOGENE RAS; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN TUMOR; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0032529165     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.16.2469     Document Type: Article

References (35)

1. Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines. Int. J. Cancer 61: 115-120.
2. ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589-23597.
3. Bartkova, J., J. Lukas, M. Strauss, and J. Bartek. 1994. The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int. J. Cancer 58: 568-573.
4. Bianchi, A.B., S.M. Fischer, A.I. Robles, E.M. Rinchik, and C.J. Conti. 1993. Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene 8: 1127-1133.
5. Dlugosz, A.A., C. Cheng, M.F. Denning, P.J. Dempsey, R.J. Coffey, Jr., and S.H. Yuspa. 1994. Keratinocyte growth factor-receptor ligands induce TGFα expression and activate the epidermal growth factor-receptor signaling pathway in cultured epidermal keratinocytes. Cell Growth & Differ. 5: 1283-1292.
6. Dlugosz, A.A., A.B. Glick, T. Tennenbaum, W.C. Weinberg, and S.H. Yuspa. 1995. Isolation and utilization of epidermal keratinocytes for oncogene research. Methods Enzymol. 254: 3-20.
7. Ha oncogene but does not block in vitro keratinocyte responses to oncogenic ras. Cancer Res. 57: 3180-3188.
8. Dvir, A., Y. Milner, O. Chomsky, C. Gilon, A. Gazit, and A. Levitzki. 1991. The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers. J. Cell Biol. 113: 857-865.
9. Fantl, V., C. Stamp, A. Andrews, I. Rosewell, and C. Dickson. 1995. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes &. Dev. 9: 2364-2372.
10. Filmus, J., A.I. Robles, W. Shi, M.J. Wong, L.L. Colombo, and C.J. Conti. 1994. Induction of cyclin D1 overexpression by activated ras. Oncogene 9: 3627-3633.
11. Gangarosa, L.M., N. Sizemore, R. Graves-Deal, S.M. Oldham, C.J. Der, and R.J. Coffey. 1997. A Raf-independent epidermal growth factor receptor autocrine loop is necessary for ras transformation of rat intestinal epithelial cells. J. Biol. Chem. 272: 18926-18931.
12. Hansen, L.A. and R.W. Tennant. 1994a. Focal transgene expression associated with papilloma development in v-Ha-ras-transgenic Tg.AC mice. Mol. Carcinog. 9: 143-156.
13. _. 1994b. Follicular origin of epidermal papillomas in v-Ha-ras transgenic Tg.AC mouse skin. Proc. Natl. Acad. Sci. 91: 7822-7826.
14. Hung, W.C., C.Y. Chai, J.S. Huang, and L.Y. Chuang. 1996. Expression of cyclin D1 and c-Ki-ras gene product in human epithelial ovarian tumors. Hum. Pathol. 27: 1324-1328.
15. Jiang, W., Y.-J. Zhang, S.M. Khan., M.C. Hollstein, R.M. Santella, S.-H. Lu, C.C. Harris, R. Montesano, and I.B. Weinstein. 1993. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. 90: 9026-9030.
16. LaBaer, J., M.D. Garrett, L.F. Stevenson, J.M. Slingerland, C. Sandhu, H.S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of CDK inhibitors. Genes & Dev. 11: 847-862.
17. Liu, J.J., J.R. Chao, M.C. Jiang, S.Y. Ng, J.J. Yen, and Y.H. Yang. 1995. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH3T3 cells. Mol. Cell. Biol. 15: 3654-3663.
18. Matsushime, H., D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J.Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14: 2066-2076.
19. ink4 protein is restricted to a subset of lung cancer cell lines that retains wildtype RB. Oncogene 9: 3375-3378.
20. Peeper, D.S., T.M. Upton, M.H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J.A. DeCaprio, and M.E. Ewen. 1997. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386: 177-181.
21. Peters, G. 1994. The D-type cyclins and their role in tumorigenesis. J. Cell. Sci. S18: 89-96.
22. Robles, A.I. and C.J. Conti. 1995. Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis 16: 781-786.
23. Robles, A.I., F. Larcher, R.B. Whalin, R. Murillas, E. Richie, I.E. Gimenez-Conti, J.L. Jorcano, and C.J. Conti. 1996. Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. Proc. Natl. Acad. 93: 7634-7638.
24. Roop, D.R., D.R. Lowy, P.E. Tambourin, J. Strickland, J.R. Harper, M. Balaschak, E.F. Spangler, and S.H. Yuspa. 1986. An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue. Nature 323: 822-824.
25. Schauer, I.E., S. Siriwardana, T.A. Langan, and R.A. Sclafani. 1994. Cyclin D1 overexpression vs. retinoblastoma inactivation: Implications for growth control evasion in non-small cell and small cell lung cancer. Proc. Natl. Acad. Sci. 91: 7827-7831.
26. Serrano, M., E. Gomez-Lahoz, R.A. DePinho, D. Beach, and D. Bar-Sagi. 1995. Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science 267: 249-252.
27. Sgambato A, E.K.-H. Han, Y.-J. Zhang, R.C. Moon, R.M. Santella, and I.B. Weinstein. 1995. Carcinogenesis 16: 2193-2198.
28. INK4 expression in primary lung cancers and cell lines. Cancer Res. 55: 505-509.
29. Sherr, C.J. 1996. Cancer cell cycles. Science 274: 1672-1677.
30. 1 cyclin-dependent kinases. Genes & Dev. 9: 1149-1163.
31. Sicinski, P., J.L. Donaher, S.B. Parker, T. Li, A. Fazeli, H. Gardner, S.Z. Haslam, R.T. Bronson, S.J. Elledge, and R.A. Weinberg. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621-630.
32. Spalding, J.W., J. Momma, M.R. Elwell, and R.W. Tennant. 1993.Chemically induced skin carcinogenesis in a transgenic mouse line (Tg.AC) carrying a v-Ha-ras gene. Carcinogenesis 14: 1335-1341.
33. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 31: 323-330.
34. Winston, J.T., S.R. Coats, Y.-Z. Wang, and W. Pledger. 1996. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12: 127-134.
35. Zarbl, H., S. Sukumar, A.V. Arthur, D. Martin-Zanca, and M. Barbacid. 1985. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature 315: 382-385.